Zemplar

Paricalcitol, sold under the brand name Zemplar, is a vitamin D analog prescribed to manage secondary hyperparathyroidism in chronic kidney disease. This oral medication helps regulate calcium and phosphorus levels. It is available as capsules for convenient daily use.

Paricalcitol is primarily used to treat secondary hyperparathyroidism in patients with chronic kidney disease, helping to lower parathyroid hormone levels. It works by mimicking the action of vitamin D, which regulates calcium and phosphorus balance in the body. This medication is often prescribed when kidney function declines, reducing the risk of bone disorders.

Paricalcitol capsules may help restore normal parathyroid hormone levels, supporting bone health and mineral balance. Users often report improved calcium absorption, which can contribute to overall well-being. Some may notice changes in energy levels as the body adjusts to the medication.

Store paricalcitol capsules at room temperature, away from moisture and heat. Keep the medication out of reach of children and pets. Inform your healthcare provider about any existing medical conditions or allergies before starting this treatment. Regular blood tests may be required to monitor calcium and phosphorus levels.

Paricalcitol may interact with other medications that affect calcium levels, such as calcium supplements or thiazide diuretics. Avoid taking magnesium-containing antacids or laxatives without consulting a healthcare provider. Certain drugs, like strong CYP3A inhibitors, may alter paricalcitol levels in the body.